![]() ![]() The profit margin, also known as the revenue ratio or gross profit ratio, is an efficiency figure used to estimate the business’s profitability by comparing net income and sales. With regard to the profitability of the company, the operating margin is currently at 0.00 percent. What Does Sana Biotechnology Inc’s Profitability and Valuation Ratios Tell Us About the Stock? A positive weighted alpha indicates the firm has done well over the course of the year, whereas one below 0 indicates that the firm has done poorly. For example, looking both at the price and the high and low measurements of 52 weeks will give you a clearer picture of the direction the price is heading. The stock is trading -57.15 percent below its 52-week high and 24.95 percent above its 52-week low. Here are five of the best ways to profit from the AI boom.Īs of the close of trading, SANA deals in the Healthcare domain. ![]() And investors like you always want to get in on the hottest stocks of tomorrow. And it's about to change everything we know about everything.Īccording to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. The artificial intelligence (AI) revolution is already here. SANA stock is trading at a margin of 9.04%, -15.18% and -29.66% apart from the 20-Day, 50-Day and 200-Day Simple Moving Average prices. Despite the fact that the share price decreased -38.09% in the last 6 months and -37.86% was subtracted to its value over the previous 3 months. The firm’s stock price fluctuated 15.88% within the last five trades and -9.74% within the last 30 trades, which was a significant change from the beginning of this year. ![]() The stock price fluctuated between $3.42 and $3.67 throughout the trading session with the volume trading being 1786683 shares, which represented a significant variation when compared to the three months average volume of 1.13 million shares. The share price of Sana Biotechnology Inc (NASDAQ:SANA) dipped -2.83% to close Monday’s market session at $3.43, lower as compared to yesterday’s close. The latest trade, Performances and Moving Averages give us the following Picture The rating was released on September 25, 2023, according to finviz. JMP Securities raised the price target for the Sana Biotechnology Inc (NASDAQ:SANA) stock to “a Mkt outperform”. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |